New Research: Adverse Events and Compounded Meds
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
New Research: Adverse Events and Compounded Meds
-
Narrated by:
-
By:
About this listen
In this episode, PSM Executive Director Shabbir Imber Safdar sits down with Dr. Kenneth McCall to explore his newly published study on the adverse events linked to compounded GLP-1 receptor agonists. Dr. McCall’s study, which analyzed data from the FDA Adverse Event Reporting System (FAERS) database, raises important safety questions about compounded semaglutide and tirzepatide. Tune in to learn about why compounded GLP-1s are so popular now, key findings from the FAERS data analysis, and future directions for safety and policy.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.